A book that you shouldn't read is this one:
http://onlinelibrary.wiley.com/doi/10.1 ... 3.297/full
To save you from loosing your time, I reproduce the abstract which says it all:
“Liberation treatment has no proven efficacy, may exacerbate underlying disease activity and has been complicated with SAEs"
But ....
If “Liberation treatment” can exacerbate MS, it is clear that MS is a vascular disease!!! They admit it.
I wonder if they will follow this research path in the future....
They want so bad to discredit CCSVI that they support it
-
1eye
- Family Elder
- Posts: 3780
- Joined: Wed Mar 17, 2010 3:00 pm
- Location: Kanata, Ontario, Canada
- Contact:
Re: They want so bad to discredit CCSVI that they support it
CCSVI research is being done, even by NASA! The propaganda is preaching to the the neurology choir, who will probably keep it on display in their offices. But it is obvious now that CCSVI may be causing the immune activity that characterizes "MS". Low blood vessel reactivity, which worsens blood vessel problems like CCSVI, may also be what's behind "MS" neural degeneration.
This unit of entertainment not brought to you by FREMULON.
Not a doctor.
"I'm still here, how 'bout that? I may have lost my lunchbox, but I'm still here." John Cowan Hartford (December 30, 1937 – June 4, 2001)
Not a doctor.
"I'm still here, how 'bout that? I may have lost my lunchbox, but I'm still here." John Cowan Hartford (December 30, 1937 – June 4, 2001)
Re: They want so bad to discredit CCSVI that they support it
I bet that's based on the PREMiSe research. There was that trend toward worse results in the treated arm vs the sham arm but it did not rise to the level of statistical significance.frodo wrote:If “Liberation treatment” can exacerbate MS, it is clear that MS is a vascular disease!!!
http://www.thisisms.com/forum/chronic-c ... 25315.htmlIn phase 2, higher MRI activity (cumulative number of new contrast-enhancing lesions [19 vs 3, p = 0.062] and new T2 lesions [17 vs 3, p = 0.066]) and relapse activity (4 vs 1, p = 0.389) were identified as nonsignificant trends in the treated vs sham arm over 6 months.